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This issue of the Asia Pacific Allergy (AP Allergy) features 
important reviews and articles on atopic dermatitis (AD). AD is 
the most common chronic inflammatory skin disease in children 
[1]. Although AD is a genetically transmitted disease, its full 
clinical expression is dependent on environmental exposures 
[2, 3]. Critical genes that predispose to AD include filaggrin 
mutations as well as genes that control allergic responses such 
as TSLP and IL-13, and innate immune responses that react to 
danger signals on initial contact between the patient and its 
environment [4]. 
Since AD often starts in infancy, the diagnosis and treatment 
of AD should focus on control of this common skin disease 
early in life. Most guidelines for the treatment of AD are written 
for physicians and subspecialists in allergy and dermatology. 
In the current issue of the AP Allergy, Lee et al. [5] have written 
a proposal on “Atopic Dermatitis Organizer (ADO) guidelines 
for children” targeting the general community involved in the 
management of AD including patients, parents, medical policy 
makers, educators as well as health care providers. It includes 
a comprehensive review of the epidemiologic characteristics 
of AD, its natural course, and an approach to the diagnosis and 
management of AD including the control of environmental 
triggers such as foods, inhalant allergens and infection as well 
as the appropriate use of anti-inflammatory therapy which has 
also been emphasized in other global guidelines and reviews 
[6, 7]. 
In this same issue of AP Allergy, Furue and colleagues 
have updated us with the current status of AD in Japan [8]. 
Interestingly, the prevalence of childhood AD varies according 
to geographic location in Japan, e.g. the prevalence of 
childhood AD is 12-13% in mainland Japan but only about 6% 
in children from Ishigaki Island, Okinawa. Assuming relative 
genetic homogeneity within Japan, this suggests that the 
environment plays an important role in clinical expression 
of AD. However, overcoming patient and family’s behavior 
about AD are difficult hurdles in bringing best care to these 
individuals, e.g. “topical steroid phobia” is common in patients 
thereby leading to undertreatment of patients and persistent 
skin inflammation in AD. 
Readers of this journal will also find several other interesting 
articles on AD. On January 28th-29th, 2011, an international 
group of AD investigators gathered in Jinan-gun, Korea 
to participate in the First West Pacific Allergy Forum on a 
“Better Environment for Atopic Dermatitis”. During the Jinan 
Conference, there was a strong emphasis on the environment 
in contributing to the clinical phenotype of AD. In a hypothesis 
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& experience article, Lee and coauthors [9] summarize their 
presentation at the Jinan Conference where they reported data 
supporting the role of indoor air quality in contributing to severity 
of AD. They found that severity of AD was reduced when patients 
were hospitalized in a low pollution hospital room suggesting 
that pollution, which has been on the rise in Korea, contributes to 
severity of AD. 
In this issue, Munasir et al. [10] reports on the role of allergic 
risk and other factors that affect the occurrence of AD in the first 
6 months of life in Indonesia. Fifty-seven percent of AD presented 
in the first month of age and immunologic changes could be 
detected in many of the patients. These findings suggest the 
importance of early intervention in AD. In a separate article from 
Thailand, Kulthanan and coauthors [11] describes the clinical 
features of extrinsic and intrinsic types of adult-onset AD. Extrinsic 
AD affected 87.5% of adult-onset AD. However both groups had 
similar severity of skin disease. Interestingly, elevated serum IgE 
levels was detected in only 37% of extrinsic AD. Positive skin 
prick test to food and inhalant allergens were more sensitive in 
detecting extrinsic AD supporting the importance of studying the 
role of specific allergens in these patients. 
In summary, the inclusion of a theme on AD in this early edition 
of the AP Allergy is an important step in the evolution of this young 
journal as AD is often the first step in the atopic march. It also 
recognizes AD as part of a multi-organ disease. Early intervention 
in the treatment of allergic diseases are important initiatives to 
promote a decline in the prevalence of AD and allergy in the 
Asian-Pacific region. I look forward to seeing more papers on the 
important topic of AD published in future issues of AP Allergy. 
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